Position in GPCR
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$20,340,178
+$10,077,483 QoQ
Shares Held
378,986
+78.0% QoQ
Ownership
0.531%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#30
of 190 holders
Holding Since
Jun 2023
12 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GPCR Over Time
Shares Held
Position Value (USD)
Derivatives in GPCR
reported options exposure · as of Dec 31, 2025CallValue
$27,820
CallShares
400
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026UBS Group AG holds $8,789,675,806 across 561 Biotechnology names. GPCR ranks #82 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RVMD |
Revolution Medicines, Inc.
|
5,450,825 | $1,020,369,609 | |
| 2 | ROIV |
Roivant Sciences Ltd.
|
17,466,641 | $618,144,423 | |
| 3 | PTGX |
Protagonist Therapeutics, Inc
|
3,399,221 | $416,676,508 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
712,259 | $353,800,411 | |
| 5 | MRNA |
Moderna, Inc.
|
4,463,211 | $312,558,664 | |
| 6 | INSM |
INSMED Inc
|
2,584,446 | $275,553,630 | |
| 7 | ABVX |
Abivax S.A.
|
1,844,918 | $245,853,771 | |
| 8 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
401,708 | $215,697,109 |
All Filings in GPCR
Export CSV
17 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $20,340,178 | 378,986 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $10,262,695 | 212,919 | Shares | Defined | 2026-05-05 | |
| 2025-12-31 | $27,820 | 400 | Call | Defined | 2026-01-29 | |
| 2025-12-31 | $14,082,274 | 202,477 | Shares | Defined | 2026-01-29 | |
| 2025-09-30 | $5,826,576 | 208,092 | Shares | Defined | 2025-11-13 | |
| 2025-09-30 | $590,800 | 21,100 | Call | Defined | 2025-11-13 | |
| 2025-06-30 | $3,172,825 | 152,981 | Shares | Defined | 2025-08-14 | |
| 2025-06-30 | $647,088 | 31,200 | Call | Defined | 2025-08-14 | |
| 2025-03-31 | $4,123,189 | 238,197 | Shares | Defined | 2025-05-13 | |
| 2025-03-31 | $154,059 | 8,900 | Call | Defined | 2025-05-13 | |
| 2024-12-31 | $6,618,987 | 244,063 | Shares | Defined | 2025-02-14 | |
| 2024-12-31 | $984,456 | 36,300 | Call | Defined | 2025-02-14 | |
| 2024-09-30 | $1,715,220 | 39,080 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $210,604 | 5,363 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $3,545,121 | 82,714 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $2,430,804 | 59,637 | Shares | Sole | 2024-02-09 | |
| 2023-06-30 | $83 | 2 | Shares | Sole | 2023-08-11 | |
| No filing history on record for this holder in this stock. | ||||||